Around 1,400 people each year die from a severe asthma attack; and asthma deaths are 50% more likely in poorest areas compared with the richest.
Now, people with severe asthma are being offered a newer type of treatment alongside their usual asthma medicines. These are known as monoclonal antibodies, also referred to as biologics.
In our latest Health Innovation Podcast, we hear from a patient and a leading clinician on how biologics are a game changer for people whose lives have been blighted by asthma. Biologics are helping them to live normal lives – and reducing the risk of a fatal attack.
Listen to the Health Innovation Podcast now on Audioboom or any major podcast channel.